Patent · US Active

Aminopyrimidine derivatives as LRRK2 modulators

US8802674B2 · kind B2 · utility

5Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2012
Grant dateAug 12, 2014
Priority date—
Expiry dateDec 12, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the formula I:or pharmaceutically acceptable salts thereof,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.